Published in Int J Obes (Lond) on November 04, 2008
Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion. Nat Commun (2016) 0.85
Tenogenic modulating insider factor: Systematic assessment on the functions of tenomodulin gene. Gene (2016) 0.81
Differential proinflammatory and oxidative stress response and vulnerability to metabolic syndrome in habitual high-fat young male consumers putatively predisposed by their genetic background. Int J Mol Sci (2013) 0.81
Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol Vis (2009) 0.76
Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing. Cell Death Dis (2017) 0.75
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet (1998) 8.02
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation (1992) 7.11
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Early growth and coronary heart disease in later life: longitudinal study. BMJ (2001) 5.25
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ (1999) 5.17
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia (1999) 5.11
Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl (1977) 4.82
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 4.62
Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand (1981) 4.53
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Osteopontin is expressed in human aortic valvular lesions. Circulation (1995) 4.16
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia (2001) 3.73
Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35
Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg (1969) 3.35
Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03
Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99
Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89
Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev (1987) 2.88
Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med (1990) 2.86
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (1999) 2.78
Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78
Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis (2004) 2.77
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73
Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Analysis of gene expression data using self-organizing maps. FEBS Lett (1999) 2.68
Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia (2009) 2.63
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol (1996) 2.60
Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia (2003) 2.60
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51
Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46
Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care (1995) 2.44
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41
Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia (2003) 2.37
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 2.29
Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28
Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl (1988) 2.26
Education and dementia: what lies behind the association? Neurology (2007) 2.26
A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia (1994) 2.25
Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23
Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol (1982) 2.20
Telecommunication and international health research. Am J Epidemiol (1988) 2.19
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16
Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med (1994) 2.09
Fetal and childhood growth and hypertension in adult life. Hypertension (2000) 2.09
International trends in mortality from stroke, 1968 to 1994. Stroke (2000) 2.09
Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun (2004) 2.07
Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord (2004) 2.07
Total cholesterol and the risk of Parkinson disease. Neurology (2008) 2.06
Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ (1999) 2.06